"The Evaluation of Stimulant Withdrawal"

首次发布于 2007 年 3 月 5 日

Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components

计划入组 50 人 · 首次发布于 2007 年 11 月 12 日

A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL.

计划入组 55 人 · 首次发布于 2007 年 11 月 2 日

hepatitis B cores (Medeva)

426c Mod Core-C4b

Core-g28v2 60mer mRNA Vaccine

Core Natural Resources

CORE SCIENTIFIC CREATIONS LTD

Israel

SCH CORE ETF UNITS

DX&VX Secures $220 Million mRNA Cancer Vaccine Licensing Deal with U.S. Biotech Partner

Dx&Vx Advances Universal COVID-19 Vaccine to Phase 2 Trials Using Virus-Like Particle Platform

Dx&Vx Advances Ferritin-Based Universal Coronavirus Vaccine to Phase 2 Trials Following Promising Phase 1 Results